Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

The no observed adverse effect level (NOAEL) was 50 mg/kg body weight/day for 28 days in male and female rats.

Key value for chemical safety assessment

Repeated dose toxicity: via oral route - systemic effects

Endpoint conclusion
Dose descriptor:
NOAEL
50 mg/kg bw/day

Additional information

In a modern, reliable guideline study, the oral administration of ortho-TDA by gavage over a period of 28 days revealed substance-related adverse findings in animals of both sexes at 250 mg/kg bw/day. There were temporary clinical signs of toxicity at this dose, with reduced body weight gain. Also at this dose findings of increased liver weight and clinical chemistry changes in both sexes indicated an effect on the liver which was identified as target organ. The no observed adverse effect level (NOAEL) under the conditions of the present study was 50 mg/kg body weight/day in male and female rats.

Justification for classification or non-classification